Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 6Neoplasms 2Lymphoma, Non-Hodgkin 2Helicobacter Infections 2Gastroesophageal Reflux 2Breast Neoplasms 2Barrett Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Compression 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Persistence of Infection With Helicobacter Pylori 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-Erosive Reflux Disease 1Neoplasm Metastasis 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hemorrhage 1Head and Neck Neoplasms 1Glioblastoma 1Gastritis, Atrophic 1Fatigue 1Familial primary gastric lymphoma 1Esophageal Neoplasms 1Delayed Bleeding 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Proton Pump Inhibitors × Clear all
NCT07076914 2025-07-22

PPI-PROTECT

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Not yet recruiting
58 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡